XOMA Royalty Corporation (LON:0M26)

Market Cap	325.07M
Revenue (ttm)	32.81M
Net Income (ttm)	-11.91M
Shares Out	n/a
EPS (ttm)	-1.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13
Average Volume	49
Open	34.97
Previous Close	35.48
Day's Range	34.97 - 34.97
52-Week Range	18.78 - 35.82
Beta	0.81
RSI	73.58
Earnings Date	Nov 5, 2025

About XOMA Royalty

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 13
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0M26

Financial Performance

In 2024, XOMA Royalty's revenue was $28.49 million, an increase of 498.72% compared to the previous year's $4.76 million. Losses were -$19.29 million, -58.33% less than in 2023.

Financial numbers in USD